NNNN (Anbio Biotechnology) OCF Margin %: 0.00% (As of Dec. 2025)


NNNN Anbio Biotechnology NNNN
24 GF Score
Price $12.46
! 2 Warning Signs
View Full Analysis

What is Anbio Biotechnology OCF Margin %?

Anbio Biotechnology NNNN +2.88% 24 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates NNNN with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Anbio Biotechnology ranks better than 72.86% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Anbio Biotechnology's Cash Flow from Operations for the six months ended in Dec. 2025 was $0.00 Mil. Anbio Biotechnology's Revenue for the six months ended in Dec. 2025 was $4.06 Mil. Therefore, Anbio Biotechnology's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Anbio Biotechnology's current OCF Yield % is 0.27%.

The historical rank and industry rank for Anbio Biotechnology's OCF Margin % or its related term are showing as below:

NNNN' s OCF Margin % Range Over the Past 10 Years
Min: -77.93   Med: 18.9   Max: 94.42
Current: 17.13

During the past 5 years, the highest OCF Margin % of Anbio Biotechnology was 94.42%. The lowest was -77.93%. And the median was 18.90%.

NNNN's OCF Margin % is ranked better than
72.86% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: 5.785 vs NNNN: 17.13

Anbio Biotechnology OCF Margin % Related Terms

Anbio Biotechnology OCF Margin % Historical Data

* Premium members only.

The historical data trend for Anbio Biotechnology's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anbio Biotechnology OCF Margin % Chart

Anbio Biotechnology Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
94.42 18.90 13.38 25.41 -77.93

Anbio Biotechnology Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only -33.76 10.24 63.40 0.00 0.00

NNNN vs ANGO, OSUR, UTMD: OCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Anbio Biotechnology's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anbio Biotechnology OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anbio Biotechnology's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Anbio Biotechnology's OCF Margin % falls into.


NNNN
24GF Score
Anbio Biotechnology NNNN
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anbio Biotechnology OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Anbio Biotechnology's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-6.739/8.647
=-77.93 %

Anbio Biotechnology's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/4.062
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Anbio Biotechnology (NNNN) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Anbio Biotechnology and its competitors. According to the industry distribution chart, Anbio Biotechnology ranks #222 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 27.1%.
Is Anbio Biotechnology's OCF Margin % too high?
Anbio Biotechnology's current OCF Margin % is 0.00%. Based on the distribution chart, Anbio Biotechnology ranks #222 out of 818 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Anbio Biotechnology has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Anbio Biotechnology's OCF Margin % compare to ANGO and OSUR?
According to the Medical Devices & Instruments industry distribution chart, Anbio Biotechnology ranks #222 out of 818 companies for OCF Margin %. This puts Anbio Biotechnology in the upper half of its industry. The industry median OCF Margin % is 5.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.79, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Anbio Biotechnology and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anbio Biotechnology's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anbio Biotechnology stock overvalued right now?
Anbio Biotechnology (NNNN) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Anbio Biotechnology's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Anbio Biotechnology (NNNN), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anbio Biotechnology Business Description

Address Friedrich-Ebert-Anlage 35-37, Frankfurt am Main, HE, DEU, 60327
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
24GF Score

Get the complete analysis for NNNN

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.46
Price